by Gina Kolata
New York Times science reporter reviews new research that certain diabetic and osteoporosis drugs, as well as the system that evaluates them, may have more risks than benefits.
by Gina Kolata
New York Times science reporter reviews new research that certain diabetic and osteoporosis drugs, as well as the system that evaluates them, may have more risks than benefits.